glycopyrronium bromide fixed-dose combination
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for glycopyrronium bromide fixed-dose combination, covering 2019-03-19 to 2019-03-19. Get the full timeline:
Most recent: Clinical Trial Update: Study to Evaluate the Efficacy and Safety of Glycopyrronium or Indacaterol Maleate and Glycopyrronium Bromide Fixed-dose Combination Regarding Symptoms and Health Status in Patients With Moderate COPD Switching From Treatment With Any Standard COPD Regimen [Phase 4]